コンテンツへスキップ
Merck

[A heart without overspeed trip unit].

Praxis (2014-04-24)
Roman Gähwiler, Christian Templin, Thomas F Lüscher, Jelena-Rima Ghadri
要旨

We report the case of a 38-year patient who presented in our outpatient clinic for cardiac evaluation and assessment as volunteer firefighter. The patient had an asymptomatic sinustachycardia, which was diagnosed at the age of 15. After we excluded secondary etiologies, as well as a postural orthostatic tachycardia syndrome (POTS) diagnosis of inappropriate sinus tachycardia (IST) was confirmed. A metoprolol therapy was established, however to resistant tachycardia, we suggested a combined therapy of Bisoprolol and Ivabradin, which resulted successfully in normocard sinus rhythm.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
(±)-メトプロロール (+)-酒石酸塩, ≥98% (titration), powder
USP
Bisoprolol fumarate, United States Pharmacopeia (USP) Reference Standard
USP
(±)-メトプロロール (+)-酒石酸塩, United States Pharmacopeia (USP) Reference Standard
Supelco
Metoprolol tartrate solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
Bisoprolol hemifumarate salt, ≥98% (HPLC), solid
Supelco
(±)-メトプロロール (+)-酒石酸塩, Pharmaceutical Secondary Standard; Certified Reference Material
Bisoprolol fumarate, European Pharmacopoeia (EP) Reference Standard
(±)-メトプロロール (+)-酒石酸塩, European Pharmacopoeia (EP) Reference Standard
Bisoprolol for peak identification, European Pharmacopoeia (EP) Reference Standard
システム適合性用ビソプロロール, European Pharmacopoeia (EP) Reference Standard